1,064 top medical experts on Adoptive Immunotherapy across 33 countries and 34 U.S. states, including 1,044 MDs (Physicians). This is based on an objective analysis of their Scientific Publications, Clinical Trials, Medicare, and NIH Grants.

  1. Adoptive Immunotherapy: Form of adoptive transfer where cells with antitumor activity are transferred to the tumor-bearing host in order to mediate tumor regression. The lymphoid cells commonly used are lymphokine-activated killer (LAK) cells and tumor-infiltrating lymphocytes (TIL). This is usually considered a form of passive immunotherapy. (From DeVita, et al., Cancer, 1993, pp.305-7, 314)
  2. Clinical guidelines are the recommended starting point to understand initial steps and current protocols in any disease or procedure:
  3. Broader Categories (#Experts): Adoptive Transfer (606).
  4. Synonyms: Adoptive Cellular Immunotherapy


  

        

                    


    Computing Expert Listing ...

);